NCT00852020 - Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

CachexiaChronic Obstructive Pulmonary DiseaseChronic Heart Failure

Interventions

DIETARY_SUPPLEMENT

oral nutrition supplement, food for special medical purposes

2 servings of 200-300 ml per day, treatment period: 16 weeks

Trial Locations (4)

Center of Cachexia Research, Department of Cardiology, Charité, Campus Virchow-Klinikum, Berlin

Praxis für Pneumologie, Schwedt/Oder, Schwedt

Regionalne Centrum Leczenia Chorób Płuc i Alergii, NZOZ ALLMED, Piekary Śląskie

Specjalista Chorób Wewnętrznych Kardiolog, Ruda Śląska